Gene · 8019
Papers2,104
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 2,104
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Novel BRD2::NUTM1 Fusion in NUT Carcinoma With Exceptional Response to Chemotherapy: A Case Report. | JTO Clin Res Rep | 2024 | 38287941 | PubTator, text mining | PubMed |
| Prevalence of S. aureus and/or MRSA in hospitalized patients with diabetic foot and establishment of LAMP methods for rapid detection of the SCCmec gene. | BMC Microbiol | 2024 | 38279164 | PubTator, text mining | PubMed |
| NSD3 in Cancer: Unraveling Methyltransferase-Dependent and Isoform-Specific Functions. | Int J Mol Sci | 2024 | 38256018 | PubTator, text mining | PubMed |
| Bromodomain-Containing Protein 9 Regulates Signaling Pathways and Reprograms the Epigenome in Immortalized Human Uterine Fibroid Cells. | Int J Mol Sci | 2024 | 38255982 | PubTator, text mining | PubMed |
| Chemical Catalysis Guides Structural Identification for the Major In Vivo Metabolite of the BET Inhibitor JQ1. | ACS Med Chem Lett | 2024 | 38229743 | PubTator, text mining | PubMed |
| BRD2 and BRD3 genes independently evolved RNA structures to control unproductive splicing. | NAR Genom Bioinform | 2024 | 38226395 | PubTator, text mining | PubMed |
| Cancer epigenetics: from laboratory studies and clinical trials to precision medicine. | Cell Death Discov | 2024 | 38225241 | PubTator, text mining | PubMed |
| Therapeutic Approaches to Targeting Androgen Receptor Splice Variants. | Cells | 2024 | 38201308 | PubTator, text mining | PubMed |
| Screening Ultra-Large Encoded Compound Libraries Leads to Novel Protein-Ligand Interactions and High Selectivity. | J Med Chem | 2024 | 38197367 | PubTator, text mining | PubMed |
| Current and future therapeutic strategies for high-grade gliomas leveraging the interplay between epigenetic regulators and kinase signaling networks. | J Exp Clin Cancer Res | 2024 | 38183103 | PubTator, text mining | PubMed |
| Combined BET and MEK Inhibition synergistically suppresses melanoma by targeting YAP1. | Theranostics | 2024 | 38169595 | PubTator, text mining | PubMed |
| Genetic correlation, shared loci, but no causality between bipolar disorder and inflammatory bowel disease: A genome-wide pleiotropic analysis. | J Affect Disord | 2024 | 38154582 | PubTator, text mining | PubMed |
| Bromodomain Proteins Epigenetically Regulate the Mitotically Associated lncRNA MANCR in Triple Negative Breast Cancer Cells. | Crit Rev Eukaryot Gene Expr | 2024 | 38073442 | PubTator, text mining | PubMed |
| Current status and perspectives of genetic testing in gastrointestinal cancer (Review). | Oncol Lett | 2024 | 38058469 | PubTator, text mining | PubMed |
| High-Grade Spindle Cell Sarcoma of the Scalp With an MGA::NUTM1 Gene Fusion in a Pediatric Patient. | Am J Dermatopathol | 2024 | 38055974 | PubTator, text mining | PubMed |
| A Phase I/II Study of GSK525762 Combined with Fulvestrant in Patients with Hormone Receptor-positive/HER2-negative Advanced or Metastatic Breast Cancer. | Clin Cancer Res | 2024 | 37992310 | PubTator, text mining | PubMed |
| Case report: Diagnosis of NUT carcinoma of hepatic origin by next-generation sequencing. | Front Oncol | 2023 | 38322288 | PubTator, text mining | PubMed |
| The Role of the AT-Rich Interaction Domain 1A Gene (ARID1A) in Human Carcinogenesis. | Genes (Basel) | 2023 | 38275587 | PubTator, text mining | PubMed |
| Epigenetic modulation of antitumor immunity and immunotherapy response in breast cancer: biological mechanisms and clinical implications. | Front Immunol | 2023 | 38268926 | PubTator, text mining | PubMed |
| Primary pulmonary nuclear protein of the testis midline carcinoma: case report and systematic review with pooled analysis. | Front Oncol | 2023 | 38264746 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8019/papers?page=6